Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues:
Obstructive sleep apnea (OSA)	$ 103,444	$ 90,453	$ 230,992	$ 158,376
Total revenues	103,444	90,453	230,992	158,376
Costs and expenses:
Costs of revenues	65,000	66,157	129,909	107,817
General and administrative	715,397	416,039	1,311,462	841,843
Depreciation and amortization	312	235	623	440
Total costs and expenses	780,709	482,431	1,441,994	950,100
Loss from operations	(677,265)	(391,978)	(1,211,002)	(791,724)
Other income (expense):
Interest expense	(707,774)	(341,178)	(1,102,403)	(669,193)
Interest income		5,994	20	5,994
Legal settlement		112,172		112,172
Forgivable SBA EIBL loan advance	10,000		10,000
Total other expense	(697,774)	(223,012)	(1,092,383)	(551,027)
Net loss	$ (1,375,039)	$ (614,990)	$ (2,303,385)	$ (1,342,751)
PER SHARE INFORMATION
Net Loss Per Common Share	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Weighted Average Number of Common Shares Outstanding	79,534,495	67,361,656	75,598,076	67,027,954